Doxazosin Treatment Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Hamsters through a Decrease in Transforming Growth Factor β Secretion

Molecular targets for antifibrotic therapy in liver disease: using magic bullets for crossfire rather than a one-sided shotgun attack

(2013) Claus Hellerbrand   GUT

Cytoglobin is expressed in hepatic stellate cells, but not in myofibroblasts, in normal and fibrotic human liver

(2013) Hiroyuki Motoyama et al.   LABORATORY INVESTIGATION

Allopurinol Reverses Liver Damage Induced by Chronic Carbon Tetrachloride Treatment by Decreasing Oxidative Stress, TGF-� Production and NF-κB Nuclear Translocation

(2013) Liseth R. Aldaba-Muruato et al.   PHARMACOLOGY

New therapeutic aspect for carvedilol: Antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage

(2012) Nadia Hamdy et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Cellular and Molecular Mechanisms of Chronic Inflammation-Associated Organ Fibrosis

(2012) Satoshi Ueha et al.   Frontiers in Immunology

The role of carvedilol in the management of portal hypertension

(2010) Dhiraj Tripathi et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Chymase inhibition attenuates tetrachloride-induced liver fibrosis in hamsters

(2010) Koji Komeda et al.   HEPATOLOGY RESEARCH

Cirrhosis Regression in Chronic Hepatitis C: An Old Tale With a New Ending

(2009) Alessio Aghemo et al.   GASTROENTEROLOGY

The natural history of hepatitis C cirrhosis after liver transplantation

(2009) Roberto J. Firpi et al.   LIVER TRANSPLANTATION

Immune Interactions in Hepatic Fibrosis

(2008) Andrew P. Holt et al.   Clinics in Liver Disease

Cellular and molecular mechanisms of fibrosis

(2007) TA Wynn   JOURNAL OF PATHOLOGY